D. Heymann, Control of communicable diseases manual, vol.20, 2015.

M. C. Maiden, M. J. Jansen-van-rensburg, J. E. Bray, S. G. Earle, S. A. Ford et al., MLST revisited: the gene-by-gene approach to bacterial genomics, Nat Rev Microbiol, vol.11, pp.728-764, 2013.

L. H. Harrison, S. I. Pelton, A. Wilder-smith, J. Holst, M. A. Safadi et al., The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease, Vaccine, vol.29, pp.3363-71, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-02083011

O. B. Harrison, H. Claus, Y. Jiang, J. S. Bennett, H. B. Bratcher et al., Description and nomenclature of Neisseria meningitidis capsule locus, Emerg Infect Dis, vol.19, pp.566-73, 2013.

R. Borrow, D. A. Caugant, M. Ceyhan, H. Christensen, E. C. Dinleyici et al., Meningococcal disease in the Middle East and Africa: findings and updates from the Global Meningococcal Initiative, J Infect, vol.75, pp.1-11, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-02013243

, Active bacterial core surveillance report, emerging infections program network, Neisseria meningitidis, vol.22, 2014.

R. Z. Jafri, A. Ali, N. E. Messonnier, C. Tevi-benissan, D. Durrheim et al., Global epidemiology of invasive meningococcal disease, Popul Health Metr, vol.11, p.17, 2013.

C. Lingani, C. Bergeron-caron, J. M. Stuart, K. Fernandez, M. H. Djingarey et al., Meningococcal meningitis surveillance in the African meningitis belt, Clin Infect Dis, vol.61, issue.5, pp.410-415, 2004.

J. Li, Y. Li, D. Wu, G. Ning, Z. Shao et al., Epidemiological characteristics of meningococcal meningitis and switching trend of serogroups of Neisseria meningitidis in China, Chin J Vaccine Immun, vol.21, pp.482-487, 2006.

Y. Zhang, D. Wei, X. Guo, M. Han, L. Yuan et al., Burden of Neisseria meningitidis infections in China: a systematic review and meta-analysis, J Glob Health, vol.6, p.20409, 2016.

J. Leimkugel, J. Da-silva, L. Pluschke, and G. , Global review of meningococcal disease. A shifting etiology, J Bacteriol Res, vol.1, pp.6-18, 2009.

L. Junhong, L. Y. Zhujun, S. Haijian, Z. Guijun, N. Zundong et al., Surveillance of meningococcal disease in China, Disease Surveillance, vol.25, pp.770-80, 2009.

C. L. Trotter, C. Lingani, K. Fernandez, L. V. Cooper, A. Bita et al., Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data, Lancet Infect Dis, vol.17, pp.867-72, 2017.

P. Stefanelli, A. Neri, P. Vacca, D. Picicco, L. Daprai et al., Meningococci of serogroup X clonal complex 181 in refugee camps, Italy. Emerg Infect Dis, vol.23, pp.870-872, 2017.

J. Lucidarme, D. M. Hill, H. B. Bratcher, S. J. Gray, M. Du-plessis et al., Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage, J Infect, vol.71, pp.544-52, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-02013265

J. Lucidarme, K. J. Scott, R. Ure, A. Smith, D. Lindsay et al., An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Euro Surveill, vol.21, 2015.

D. Granoff, R. Borrow, and . Meningococcal, , pp.399-434, 2008.

E. Murphy, L. Andrew, K. L. Lee, D. A. Dilts, L. Nunez et al., Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis, J Infect Dis, vol.200, pp.379-89, 2009.

U. Vogel, M. K. Taha, J. A. Vazquez, J. Findlow, H. Claus et al., Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis, vol.13, pp.416-441, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02093031

M. M. Mustapha, J. W. Marsh, M. G. Krauland, J. O. Fernandez, A. P. De-lemos et al., Genomic investigation reveals highly conserved, mosaic, recombination events associated with capsular switching among invasive Neisseria meningitidis serogroup W sequence type (ST)-11 strains, Genome Biol Evol, vol.8, pp.2065-75, 2016.

M. Achtman, Clonal spread of serogroup A meningococci: a paradigm for the analysis of microevolution in bacteria, Mol Microbiol, vol.11, pp.15-22, 1994.

J. F. Wang, D. A. Caugant, X. Li, X. Hu, J. T. Poolman et al., Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China, Infect Immun, vol.60, pp.5267-82, 1992.

A. Agnememel, E. Hong, D. Giorgini, V. Nunez-samudio, A. E. Deghmane et al., Neisseria meningitidis serogroup X in sub-Saharan Africa, Emerg Infect Dis, vol.22, pp.698-702, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-02060243

J. F. Aguilera, A. Perrocheau, C. Meffre, and S. Hahne, Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Emerg Infect Dis, vol.8, pp.761-768, 2000.

M. K. Taha, H. Claus, M. Lappann, F. J. Veyrier, A. Otto et al., Evolutionary events associated with an outbreak of meningococcal disease in men who have sex with men, PLoS ONE, vol.11, p.154047, 2016.

Z. Shao, W. Li, J. Ren, X. Liang, L. Xu et al., Identification of a new Neisseria meningitidis serogroup C clone from Anhui province, China, Lancet, vol.367, pp.419-442, 2006.

B. Zhu, Z. Xu, P. Du, L. Xu, X. Sun et al., Sequence type 4821 clonal complex serogroup B Neisseria meningitidis in China, Emerg Infect Dis, vol.21, pp.925-957, 2015.

Z. Shao, H. Zhou, Y. Gao, H. Ren, L. Xu et al., Neisseria meningitidis serogroup W135, China. Emerg Infect Dis, vol.16, pp.348-357, 2010.

H. Zhou, W. Liu, L. Xu, L. Deng, Q. Deng et al., Spread of Neisseria meningitidis serogroup W clone, China. Emerg Infect Dis, vol.19, pp.1496-1505, 2013.

C. Chen, T. G. Zhang, J. G. He, J. Wu, L. J. Chen et al., A first meningococcal meningitis case caused by serogroup X Neisseria meningitidis strains in China, Chin Med J, vol.121, pp.664-670, 2008.

J. Pan, P. Yao, H. Zhang, X. Sun, H. He et al., The case of a new sequence type 7 serogroup X Neisseria meningitidis infection in China: may capsular switching change serogroup profile?, Int J Infect Dis, vol.29, pp.62-66, 2014.

L. C. Guo, X. C. Liu, Q. Y. Xu, Y. S. Yiu, Y. Cai et al., Epidemiological analysis on serogroup Y Neisseria meningitidis firstly isolated from patient in Tianjin, Zhonghua Yu Fang Yi Xue Za Zhi, vol.50, pp.825-832, 2016.

Q. Wang, Z. Shao, X. Wang, Y. Gao, M. Li et al., Genetic study of capsular switching between Neisseria meningitidis sequence type 7 serogroup A and C strains, Infect Immun, vol.78, pp.3883-3891, 2010.

B. Zhu, P. Yao, L. Zhang, Y. Gao, L. Xu et al., Genetic analysis of Neisseria meningitidis sequence type 7 serogroup X originating from serogroup A, Infect Immun, vol.85, 2017.

Z. Xu, P. Du, B. Zhu, L. Xu, H. Wang et al., Phylogenetic study of clonal complex (CC)198 capsule null locus (cnl) genomes: a distinctive group within the species Neisseria meningitidis, Infect Genet Evol, vol.34, pp.372-379, 2015.

J. Li, Y. Li, Z. Shao, L. Li, Z. Yin et al., Prevalence of meningococcal meningitis in China from, Vaccine, vol.33, pp.1092-1099, 2005.

J. Li, Y. Li, Z. Yin, G. Ning, D. Wu et al., Epidemiological and clinical characteristics of serogroup C meningococcal meningitis in China during 2008-2013, Chin J Vaccine Immun, vol.21, pp.168-72, 2015.

L. Yang, Z. Shao, X. Zhang, L. Xu, J. Peng et al., Genotypic characterization of Neisseria meningitidis serogroup B strains circulating in China, J Infect, vol.56, pp.211-219, 2008.

J. Yao and B. J. Wang, Genetic variation of 25 Y-chromosomal and 15 autosomal STR loci in the Han Chinese population of Liaoning province, PLoS ONE, vol.11, p.160415, 2016.

, China Statistics Press, ChinA STATISTICS YEARBOOK, 2016.

J. Liang, M. Liu, Z. Zheng, C. Wu, and X. Shao, Antibody levels to serogroup C Neisseria meningitidis in a healthy population of Guangdong Province, Chin J Vaccine Immun, vol.21, pp.177-80, 2010.

M. Chen, Q. Guo, Y. Wang, Y. Zou, G. Wang et al., Shifts in the antibiotic susceptibility, serogroups, and clonal complexes of Neisseria meningitidis in Shanghai, China: a time trend analysis of the pre-quinolone and quinolone eras, PLoS Med, vol.12, p.1001838, 2015.

B. Q. Zhu, L. Xu, M. C. Li, H. Y. Ren, G. Z. Tian et al., Establishment and application of TaqMan real-time PCR in detection and serogrouping of Neisseria meningitidis, Zhonghua Liu Xing Bing Xue Za Zhi, vol.29, pp.360-364, 2008.

A. Birtles, K. Hardy, S. J. Gray, S. Handford, E. B. Kaczmarski et al., Multilocus sequence typing of Neisseria meningitidis directly from clinical samples and application of the method to the investigation of meningococcal disease case clusters, J Clin Microbiol, vol.43, pp.6007-6021, 2005.

G. Liu, E. Zhang, H. Chen, S. Li, C. W. Jiang et al., Risk factors of poor prognosis in children with purulent meningitis, J Clin Pediatr, vol.29, pp.148-52, 2011.

Y. Li, Z. Yin, Z. Shao, M. Li, X. Liang et al., Population-based surveillance for bacterial meningitis in China, Emerg Infect Dis, vol.20, pp.61-70, 2006.

Y. Yang, Z. Leng, X. Shen, D. Lu, Z. Jiang et al., Acute bacterial meningitis in children in Hefei, China 1990-1992, Chin Med J, vol.109, pp.385-393, 1996.

L. Y. Guo, Z. X. Zhang, X. Wang, P. P. Zhang, W. Shi et al., Clinical and pathogenic analysis of 507 children with bacterial meningitis in Beijing, Int J Infect Dis, vol.50, pp.38-43, 2016.

L. Zhang, C. Wang, and Y. Wang, Clinical and etiological analysis of 146 cases of bacterial meningitis with clear pathogens, Chin J Evid Based Pediatr, vol.8, pp.161-167, 2013.

H. Wang, C. Hua, and J. Li, Pathogens distribution and drug resistance from cerebrospinal fluid culture from, 2007.

, J Clin Pediatr, vol.34, pp.533-540, 2016.

L. Zhang-yan, S. Li-zhi, G. -. , L. , M. W. Xiao-juan et al., Sentinel surveillance and etiological analysis of acute bacterial meningitis in Shandong, Dis Surveill, vol.29, pp.48-51, 2006.

H. Y. Chen, Recurrent purulent meningitis in children: analysis of the cause and follow up with 33 cases, Beijing Med, vol.6, pp.479-83, 2011.

P. Zhang, N. Zhang, L. Liu, K. Zheng, L. Zhu et al., Polymorphisms of toll-like receptors 2 and 9 and severity and prognosis of bacterial meningitis in Chinese children, Sci Rep, vol.7, p.42796, 2017.

M. C. Brouwer, A. R. Tunkel, and D. Van-de-beek, Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis, Clin Microbiol Rev, vol.23, pp.467-92, 2010.

E. Miller, D. Salisbury, and M. Ramsay, Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story, Vaccine, vol.20, issue.1, pp.58-67, 2001.

M. C. Maiden, A. B. Ibarz-pavon, R. Urwin, S. J. Gray, N. J. Andrews et al., Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity, J Infect Dis, vol.197, pp.737-780, 2008.

A. K. Takala, J. Eskola, M. Leinonen, H. Kayhty, A. Nissinen et al., Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine, J Infect Dis, vol.164, pp.982-988, 1991.

R. Dagan, R. Melamed, M. Muallem, L. Piglansky, D. Greenberg et al., Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine, J Infect Dis, vol.174, pp.1271-1279, 1996.

P. A. Kristiansen, F. Diomande, A. K. Ba, I. Sanou, A. S. Ouedraogo et al., Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity, Clin Infect Dis, vol.56, pp.354-63, 2013.

R. C. Read, D. Baxter, D. R. Chadwick, S. N. Faust, A. Finn et al., Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial, Lancet, vol.384, pp.2123-2154, 2014.

H. Campbell, N. Andrews, R. Borrow, C. Trotter, and E. Miller, Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity, Clin Vaccine Immunol, vol.17, pp.840-847, 2010.

R. Borrow, D. Goldblatt, N. Andrews, J. Southern, L. Ashton et al., Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United Kingdom, J Infect Dis, vol.186, pp.1353-1360, 2002.

C. Auckland, S. Gray, R. Borrow, N. Andrews, D. Goldblatt et al., Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom, J Infect Dis, vol.194, pp.1745-52, 2006.

S. N. Ladhani, N. J. Andrews, P. Waight, B. Hallis, M. Matheson et al., Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule, Vaccine, vol.33, pp.648-55, 2015.

M. E. Ramsay, N. J. Andrews, C. L. Trotter, E. B. Kaczmarski, and E. Miller, Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis, BMJ, vol.326, pp.365-371, 2003.

K. A. Cartwright, J. M. Stuart, D. M. Jones, and N. D. Noah, The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica, Epidemiol Infect, vol.99, pp.591-601, 1987.

J. Maclennan, G. Kafatos, K. Neal, N. Andrews, J. C. Cameron et al., Social behavior and meningococcal carriage in British teenagers, Emerg Infect Dis, vol.12, pp.950-957, 2006.

J. Donnelly, D. Medini, G. Boccadifuoco, A. Biolchi, J. Ward et al., Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines, Proc Natl Acad Sci, vol.107, pp.19490-19495, 2010.

S. Parikh, K. Beebeejaun, H. Campbell, S. Ribeiro, C. Ward et al., Early evidence of effectiveness against group B meningococcal disease and population impact of a reduced infant schedule with 4CMenB vaccine in England, Lancet, vol.338, pp.2775-82, 2016.

K. Sunasara, J. Cundy, S. Srinivasan, B. Evans, W. Sun et al., Bivalent rLP2086 (Trumenba(R)): development of a well-characterized vaccine through commercialization, Vaccine, 2017.

R. C. Griggs, M. Batshaw, M. Dunkle, R. Gopal-srivastava, K. E. Krischer et al., Clinical research for rare disease: opportunities, challenges, and solutions, Mol Genet Metab, vol.96, pp.20-26, 2009.

H. M. Soeters, J. Dinitz-sklar, P. A. Kulkarni, J. R. Macneil, L. A. Mcnamara et al., Serogroup B meningococcal disease vaccine recommendations at a University, Emerg Infect Dis, vol.23, pp.867-876, 2016.

P. Rouaud, A. Perrocheau, M. K. Taha, C. Sesboue, A. M. Forgues et al., Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, Euro Surveill, vol.11, pp.178-81, 2003.

M. K. Taha, M. L. Zarantonelli, J. M. Alonso, L. M. Naess, J. Holst et al., Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks, Vaccine, vol.25, pp.2537-2545, 2007.

J. Sevestre, E. Hong, V. Delbos, A. Terrade, E. Mallet et al., Durability of immunogenicity and strain coverage of MenBvac, a meningococcal vaccine based on outer membrane vesicles: lessons of the Normandy campaign, Vaccine, vol.35, pp.4029-4062, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-02013259

F. Caron, V. Delbos, E. Houivet, A. E. Deghmane, J. P. Leroy et al., Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac, Vaccine, vol.30, pp.5059-62, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-02085547

B. Greenwood, Manson lecture. Meningococcal meningitis in Africa, Trans R Soc Trop Med Hyg, vol.93, pp.341-53, 1999.

J. M. Okwo-bele, F. M. Laforce, R. Borrow, and M. P. Preziosi, Documenting the results of a successful partnership: a new meningococcal vaccine for Africa, Clin Infect Dis, vol.61, issue.5, pp.389-90, 2015.

D. M. Daugla, J. P. Gami, K. Gamougam, N. Naibei, L. Mbainadji et al., Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study, Lancet, vol.383, pp.40-47, 2014.

K. Gamougam, D. M. Daugla, J. Toralta, C. Ngadoua, F. Fermon et al., Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Emerg Infect Dis, vol.21, pp.115-123, 2013.

S. Methylin®, METHYLIN-methylphenidate hydrochloride solution, ?setid=9e3c22d9-71d9-46a7-b315-8021c94c4bec. Chewable tables, 2015.

, Pneumococcal meningitis outbreaks in sub-Saharan Africa, Wkly Epidemiol Rec, vol.91, pp.298-302, 2016.